Top Markets
Coin of the day
Arch Biopartners Inc. Arch Biopartners Inc.

Arch Biopartners Inc.

ARCH
Rangering i aksjer #25408
Arch Biopartners Inc. is a biotechnology firm dedicated to devising... Arch Biopartners Inc. is a biotechnology firm dedicated to devising groundbreaking solutions for both medical and commercial applications. A significant focus for the company is the advancement of Metablok, a key therapeutic agent designed to address or avert dipeptidase-1 driven inflammation in critical organs such as the lungs, liver, and kidneys. This inflammatory response can lead to profound organ dysfunction or complete failure, particularly in conditions like sepsis and COVID-19. Moreover, Arch Biopartners is developing AB569, an experimental medication intended to combat antibiotic-resistant bacterial infections, primarily through topical application on wounds. Their innovative product pipeline also features Borg, a specialized peptide-solid surface interface developed to hinder biofilm formation and lessen material corrosion. Lastly, MetaMx involves synthetic compounds engineered to target the cells that initiate brain tumors and invasive glioma cells. The company's operations are based out of Toronto, Canada.
Aksjekurs
$0.73393689
Sist synkronisert: 2026-08-20
Markedsverdi
$49.86M
Endring (1 dag)
-8.26%
Endring (1 år)
-38.15%
Land
CA
Handel Arch Biopartners Inc. (ARCH)

Kategori

Aksjeprishistorikk for Arch Biopartners Inc. (ARCH)
Høyeste sluttskurs: $0.80 den 2026-08-01

Laveste sluttskurs: $0.24 den 2010-05-01
Aksjeprishistorikk for Arch Biopartners Inc. fra 2010 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -23.16%
2025 -30.82%
2024 20.19%
2023 -48.03%
2022 -33.91%
2021 176.41%
2020 54.21%
2019 -26.71%
2018 185.93%
2017 8.76%
2016 42.45%
2015 -21.16%
2014 48.45%
2013 -6.69%
2012 -40.44%
2011 -46.45%
2010 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.33 -18.49%
AU
$761.87 8.65%
CH
$130.43 397.46%
US